ToxSci Advance Access published online on September 11, 2003
Toxicological Sciences, doi:10.1093/toxsci/kfg231
Toxicological Sciences © Society of Toxicology 2003; all rights reserved
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, NH 03755
* To whom correspondence should be addressed. E-mail: abarchowsky{at}ceoh.pitt.edu.
Trivalent inorganic arsenic (arsenite, arsenic trioxide, As(III)) is currently being used to treat hematologic tumors and is being investigated for treating solid tumors. However, low concentrations of As(III) stimulate vascular cell proliferation in cell culture; although this has not been confirmed in vivo. Therefore, the hypothesis that As(III) enhances blood vessel growth (angiogenesis) and tumorigenesis was tested in two in vivo models of angiogenesis and a model of tumor growth. In the first, arsenite caused a dose-dependent increase in vessel density in a chicken chorioallantoic membrane (CAM) assay. The threshold As(III) concentration for this response was 0.033 µM and inhibition of vessel growth was observed at concentrations greater than 1 µM. Mouse Matrigel implants were used to test the angiogenic effects of As(III) in an adult mammalian system. Mice were injected with 0.8-80 µg/kg As(III)/day over a three week period. During the last two weeks, Matrigel plugs were placed on the abdominal wall. Low and high doses of As(III) synergized with fibroblast growth factor-2 (FGF-2) in the Matrigel to increase vessel density in the Matrigel, while a middle dose was no different than control injections. To test the effects of As(III) on tumor growth, GFP-labeled B16-F10 mouse melanoma cells were implanted in nude mice, which received biweekly injections of 0.5-5.0 mg/kg As(III). Significant tumor growth and lung metastasis was seen in all animals with the largest tumors occurring in animals treated with lower doses of As(III). These studies support the hypothesis and indicate that induction of angiogenesis, enhanced tumor growth, and metastasis are potential dose-dependent toxic side effects of arsenic therapies.
© 2003 Society of Toxicology
Carcinogenicity
Arsenic Stimulates Angiogenesis and Tumorigenesis in Vivo
2 Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190
3 Department of Physiology, Dartmouth Medical School, Hanover, NH 03755
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Navas-Acien and E. Guallar Measuring Arsenic Exposure, Metabolism, and Biological Effects: The Role of Urine Proteomics Toxicol. Sci., November 1, 2008; 106(1): 1 - 4. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kumar, Q. Gao, Y. Ning, Z. Wang, P. H. Krebsbach, and P. J. Polverini Arsenic trioxide enhances the therapeutic efficacy of radiation treatment of oral squamous carcinoma while protecting bone Mol. Cancer Ther., July 1, 2008; 7(7): 2060 - 2069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Prozialeck, J. R. Edwards, D. W. Nebert, J. M. Woods, A. Barchowsky, and W. D. Atchison The Vascular System as a Target of Metal Toxicity Toxicol. Sci., April 1, 2008; 102(2): 207 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Klei and A. Barchowsky Positive Signaling Interactions between Arsenic and Ethanol for Angiogenic Gene Induction in Human Microvascular Endothelial Cells Toxicol. Sci., April 1, 2008; 102(2): 319 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Andrew, V. Bernardo, L. A. Warnke, J. C. Davey, T. Hampton, R. A. Mason, J. E. Thorpe, M. A. Ihnat, and J. W. Hamilton Exposure to Arsenic at Levels Found in U.S. Drinking Water Modifies Expression in the Mouse Lung Toxicol. Sci., November 1, 2007; 100(1): 75 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. He, R. J. Greenwell, D. M. Brooks, L. Calderon-Garciduenas, H. D. Beall, and J. D. Coffin Arsenic Exposure in Pregnant Mice Disrupts Placental Vasculogenesis and Causes Spontaneous Abortion Toxicol. Sci., September 1, 2007; 99(1): 244 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Mousa, L. O'Connor, T. G. Rossman, and E. Block Pro-angiogenesis action of arsenic and its reversal by selenium-derived compounds Carcinogenesis, May 1, 2007; 28(5): 962 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen, P. Factor-Litvak, G. R. Howe, J. H. Graziano, P. Brandt-Rauf, F. Parvez, A. van Geen, and H. Ahsan Arsenic Exposure from Drinking Water, Dietary Intakes of B Vitamins and Folate, and Risk of High Blood Pressure in Bangladesh: A Population-based, Cross-sectional Study Am. J. Epidemiol., March 1, 2007; 165(5): 541 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Shaw, K. Gabor, E. Hand, A. Lankowski, L. Durant, R. Thibodeau, C. R. Stanton, R. Barnaby, B. Coutermarsh, K. H. Karlson, et al. Role of glucocorticoid receptor in acclimation of killifish (Fundulus heteroclitus) to seawater and effects of arsenic Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R1052 - R1060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Uzick Naturopathic Approaches Integr Cancer Ther, September 1, 2005; 4(3): 253 - 258. [PDF]
|
|
|
|
|
|
C. D. Kamat, D. E. Green, S. Curilla, L. Warnke, J. W. Hamilton, S. Sturup, C. Clark, and M. A. Ihnat Role of HIF Signaling on Tumorigenesis in Response to Chronic Low-Dose Arsenic Administration Toxicol. Sci., August 1, 2005; 86(2): 248 - 257. [Abstract] [Full Text] [PDF]
|
|